Visit our Location
11860 Vista Del Sol Dr Suite 105,
El Paso, TX 79936
Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Tag: autonomic regulation

ChiroMedBlogautonomic regulation
Integrative Hormone Health and Metabolic Resilience

Integrative Hormone Health and Metabolic Resilience

Integrative Hormone Health and Metabolic Resilience

Abstract

This educational post presents a practical, evidence-based roadmap for addressing complex hormone health, pelvic bleeding, urinary and infectious issues, metabolic and thyroid considerations, perimenopause, sleep, cognition, and gut-brain integration. As Dr. Alexander Jimenez, I present evidence-based strategies integrating precision diagnostics, lifestyle medicine, nutraceuticals, and chiropractic care, informed by my clinical experience and peer-reviewed research. I share structured decision trees for discontinuing high-risk oral contraceptives, evaluating postmenopausal bleeding, optimizing testosterone therapy, avoiding unnecessary antibiotic treatments, supporting reproductive planning with genetic counseling, and stabilizing mood and cognition through gut, sleep, and nervous system interventions. This post provides clear protocols, rationales, and physiology so you can understand not only what to do but also why it works.

Introduction: How I Approach Complex Cases With Modern, Evidence-Based Care

As a clinician working at the intersection of chiropractic medicine, family practice, functional medicine, and integrative care, I see patients whose stories rarely fit into clear categories. The questions range from “Why am I bleeding months after menopause?” to “Is my testosterone causing water retention?” to “Do we treat group A strep in urinary infections?” to “How do we support a young adult with ADHD without overmedicating?” The answers require a blend of physiology, clinical judgment, careful monitoring, and a collaborative strategy that respects both modern guidelines and whole-person health.

Over the years, I have refined protocols based on the current literature and what truly helps patients improve function and quality of life. Below, I walk you through a set of conceptual areas, each one grounded in research and enhanced by integrative chiropractic care to optimize neuromusculoskeletal balance, autonomic regulation, and rehabilitation outcomes. My goal is to help patients and clinicians understand the “why” behind every step.

Hormone Therapy Foundations: Physiology, Protocols, and Safety

Key themes

  • Hormones are signals that modulate cellular function across systems, including the nervous, immune, cardiovascular, bone, and metabolic networks.
  • The body seeks homeostasis; our job is to support signaling patterns, receptor sensitivity, and tissue-level responses without overdriving any pathway.
  • Precision dosing and monitoring reduce adverse effects and improve outcomes.

Physiological underpinnings

  • Estrogen supports endothelial function, neural plasticity, bone mineralization, and collagen integrity. In perimenopause, oscillations in estradiol can cause unpredictable vasomotor symptoms, mood shifts, and bleeding pattern variability as ovaries intermittently “kick back in.”
  • Progesterone modulates GABAergic tone in the brain, stabilizes the endometrium, and balances estrogenic proliferation in uterine tissue. It supports sleep and reduces anxiety for many individuals through neurosteroid pathways.
  • Testosterone influences erythropoiesis, muscle protein synthesis, libido, and mood. Excessive levels can cause fluid retention, acne, and elevations in hematocrit; insufficient levels may present with fatigue, low motivation, and reduced muscle mass.

Clinical rationale

  • Use hormone therapy to restore physiologic ranges, not to chase symptoms. We titrate to the lowest effective dose that stabilizes a patient’s quality of life and biomarkers.
  • Cycle-based variability matters. In perimenopause, bleeding after several months of amenorrhea can occur due to transient estrogen rises. The key is ruling out pathology while acknowledging normal variability.

How integrative chiropractic care fits

  • Autonomic regulation: Chiropractic approaches can reduce sympathetically mediated tension, improve sleep and recovery, and enhance the body’s ability to integrate hormone signaling by stabilizing neuromusculoskeletal inputs.
  • Pelvic biomechanics: Pelvic floor and sacroiliac alignment impact pelvic organ function, venous return, and lymphatic flow—relevant for pelvic congestion and postmenopausal bleeding comfort.
  • Rehab progression: Strengthening and mobility prescriptions support bone density, insulin sensitivity, and mood stabilization, synergizing with hormone therapy.

Decision-Making in Perimenopause and Postmenopausal Bleeding

What is typical, and when to evaluate

  • Perimenopause is characterized by high-low-high estrogen fluctuations. A woman who has been amenorrheic for several months may experience a spontaneous bleed when estradiol rises, and the endometrium responds.
  • After 12 months of amenorrhea, any new bleeding is considered postmenopausal bleeding and warrants evaluation to exclude endometrial pathology.

Evaluation steps and reasoning

  • History and risk factors: Age, obesity, nulliparity, unopposed estrogen exposure, and tamoxifen use.
  • Examination and imaging: We employ transvaginal ultrasound to assess endometrial thickness and look for polyps or fibroids. If the endometrium is thickened or focal lesions are suspected, sonohysterography or hysteroscopy with biopsy may be indicated.
  • Endometrial biopsy: Rules out hyperplasia or carcinoma when imaging or clinical suspicion is high.

Why this protocol

  • The goal is to distinguish physiologic perimenopausal variability from structural lesions. Polyps and fibroids are common; treating them appropriately (e.g., uterine artery embolization for fibroids) allows safe resumption of hormone therapy when indicated. I have seen patients resume progesterone or combined therapy with no further withdrawal bleeds after targeted intervention, consistent with the literature on treating the underlying structural cause rather than halting all hormone care.

Integrative chiropractic role

  • Pelvic alignment and diaphragm-pelvic floor coordination can reduce pelvic venous stasis, relieve low back and sacral tension, and improve tolerance to gynecologic evaluations and interventions. We incorporate breath mechanics, thoracolumbar mobility, and hip stability into a comprehensive plan.

Safety Considerations: Discontinuing High-Risk Oral Contraceptives

Why oral contraceptives may pose a risk

  • Combined oral contraceptives elevate sex hormone-binding globulin (SHBG), often reducing free testosterone and contributing to fatigue or low libido.
  • They increase the risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), especially in individuals with cardiovascular risk factors.

Decision tree

  • If a patient has used combined oral contraceptives for more than a decade and presents with risk factors (e.g., prior stents, smoking, immobility), counseling focuses on discontinuation and transitioning to safer options such as levonorgestrel intrauterine devices, which carry lower systemic risk and reduce bleeding.
  • We explain the mechanism: estrogen-containing pills increase clotting factors and SHBG; removing the exposure reduces thrombotic risk and can normalize androgen availability.

Integrative chiropractic role

  • We provide postural and movement interventions to improve venous return, diaphragmatic excursion, and lymphatic drainage, which are particularly helpful for patients recovering from VTE or those with high sedentary time.

Addressing Testosterone Therapy: Dosing, Monitoring, and Side Effects

Clinical questions often raised

  • Is testosterone causing fluid retention or bloating after weight changes?
  • How do we reassure when total testosterone is high-normal (e.g., 1200–1400 ng/dL) but symptoms are stable?

Physiology and rationale

  • Testosterone can transiently increase sodium and water retention via renal effects and raise hematocrit through erythropoietic stimulation. However, weight loss from improved insulin sensitivity or caloric balance often reduces the need for prior dosing levels; hence, symptoms may reflect recalibration rather than pathology.
  • We monitor hematocrit, PSA (for males), lipids, liver enzymes, and consider estradiol levels due to aromatization. Our aim is symptom stability, biomarker safety, and improvements in functional strength.

Action steps

  • If bloating or water retention appears, reassess dosage, salt intake, sleep quality, and training volume. Consider a small dose reduction and recheck labs after 6–8 weeks.
  • Avoid co-treatments that claim to preserve sperm count without evidence. For example, prescribing hCG solely to “preserve sperm count” in men on testosterone may not produce the desired outcome; we test and verify. If fertility is a priority, collaborating with reproductive specialists and pausing testosterone therapy can be necessary.

Integrative chiropractic role

  • Strength programming, joint alignment, and ribcage mechanics enhance breathing efficiency and venous return, reducing perceived bloating. Neuromuscular training supports lean mass accrual and mitigates discomfort from dose adjustments.

Urinary Tract Infections: Targeted Treatment Without Overreach

Common misconceptions

  • Treating group A streptococcus in urinary tract infections is not standard. Most UTIs are caused by E. coli or other gram-negative organisms; management is guided by culture and sensitivity results. Over-treating non-dominant organisms increases the risk of antibiotic resistance without benefit.

Clinical reasoning

  • We treat the pathogen identified as the primary cause with the narrowest effective antibiotic. Recurrent staph skin infections in the history do not automatically preclude medications such as amitriptyline (Elavil); decisions hinge on the indication, risk-benefit profile, and current clinical status.

Integrative chiropractic role

  • Autonomic balance and pelvic floor rehabilitation can reduce urgency and improve voiding patterns. Addressing lumbopelvic mechanics helps recurrent lower urinary symptoms through improved nerve supply and muscular coordination.

Genetic Counseling, Family Planning, and Ethical Care

For a 28-year-old considering future family planning

  • We integrate genetic counseling to clarify inherited risks, discuss preconception optimization, and interpret comprehensive metabolic panels as context (not fate).
  • This process emphasizes empowerment, clear communication, and second opinions when uncertainty or anxiety arises.

Why this pathway matters

  • Patients deserve transparent, non-alarmist explanations and access to tools that inform long-term decisions. Genetic insights help tailor lifestyle and screening without defining identity.

Integrative chiropractic role

  • Stress-reduction techniques, breathing drills, and gentle adjustments can downshift autonomic arousal, making complex counseling sessions more manageable and improving adherence to health plans.

Perimenopause: The High-Low-High Pattern and Practical Management

Understanding the oscillations

  • The ovaries may intermittently produce estrogen, causing the return of bleeding after months of amenorrhea. This is often normal perimenopausal behavior, although each episode should be contextualized by risk, age, and prior patterns.

Clinical approach

  • Reassure and monitor rather than over-test if the clinical picture aligns with typical perimenopause. If bleeding persists or presents with red flags, proceed to imaging and biopsy per protocols.

Integrative chiropractic role

  • Managing thoracic mobility and ribcage mechanics improves hot-flash tolerance by enhancing thermoregulatory mechanisms and heat dissipation. Pelvic floor training aids comfort and reduces cramping sensations.

Gut-Brain Axis, ADHD, Anxiety, and Sleep

Core connections

  • Gut microbiome status influences neurotransmitter production, inflammation, and mood regulation. Progesterone’s GABAergic effects support sleep and anxiety reduction, while estrogen modulates serotonergic tone and vascular responsiveness in the brain.

Clinical strategy

  • For ADHD-like symptoms and anxiety, we start with sleep hygiene, nutritional optimization, and gut support. Targeting motility and microbiota diversity can improve cognition and mood. If motility is sluggish, we consider dietary fiber, hydration, and mitochondrial support. Medication decisions are individualized and layered after foundational physiology is stabilized.

Integrative chiropractic role

  • Vagal tone enhancement through cervical and thoracic work, diaphragmatic breathing, and postural correction helps reduce anxiety and supports sleep architecture. Structured movement plans improve executive function via increased prefrontal perfusion and neurotrophic signaling.

Thyroid, Iodine, and Halides: Keeping Science Front and Center

Clarifying iodine

  • Iodine is essential for thyroid hormone synthesis. However, blanket claims that other halides “replace” iodine and universally cause cancer are not supported by the weight of evidence. Excess iodine can trigger thyroid dysfunction in susceptible individuals; deficiency can impair hormone production. Balance is key.

Clinical approach

  • We screen thyroid function when clinically indicated, not reflexively in all cases. We consider TSH, free T4, free T3, and thyroid antibodies when symptoms warrant testing. Supplement iodine only when indicated, at appropriate doses, while monitoring for autoimmune flares.

Integrative chiropractic role

  • Address cervical mechanics and stress patterns that influence perceived throat tightness and fatigue. Movement prescriptions support metabolism and thermoregulation while we calibrate thyroid care using objective data.

Postmenopausal Bleeding With Structural Etiologies: Polyps and Fibroids

What we see

  • Some patients on hormone therapy may develop postmenopausal bleeding due to previously unrecognized endometrial polyps or uterine fibroids. In my practice, we often discover these via ultrasound.

Interventions and outcomes

  • Endometrial polyps may require removal. Fibroids can be managed via medical therapy, myomectomy, or uterine artery embolization. I have observed that patients often resume hormone therapy afterward without recurrence of bleeding when the structural issue is corrected—consistent with published outcomes showing durable symptom control.

Integrative chiropractic role

  • Post-procedural care includes pelvic floor re-education, lower abdominal fascial mobility, and graded return to activity, which helps circulation and comfort during recovery.

Medication Stewardship: When to Pause, Taper, or Discontinue

Principles

  • Choose the least intensive intervention that achieves the therapeutic goal.
  • Reassess regularly; what helped at one stage may need adjustment after weight loss, improved sleep, or reduced stress.

Decision-making examples

  • Amitriptyline for neuropathic pain or sleep: Evaluate infection risk based on context and history, but prior staph skin infections do not automatically disqualify its use. Monitor and adjust.
  • Oral contraceptives used long-term in individuals with cardiovascular risk: Favor discontinuation and safer alternatives due to PE/DVT/stroke risk and elevated SHBG.

Integrative chiropractic role

  • Taper plans are supported by autonomic regulation to reduce withdrawal symptoms. Breathing drills, gentle manual therapy, and pacing reduce the risk of relapse.

Communication and Counseling: Clarity Over Panic

What patients need

  • Transparent explanations, second-opinion encouragement when appropriate, and harm-reduction strategies.
  • Avoid panic by presenting data, decision trees, and timelines so patients can move forward with confidence.

Clinical scripts I use

  • “Your bleeding may be part of perimenopausal variability, but we’ll verify with imaging so we don’t miss a structural cause.”
  • “Your contraceptive pill increases clot risk and SHBG; an IUD can offer contraception without raising clotting factors.”
  • “Your testosterone level is high-normal; your symptoms suggest you may simply need a small dose recalibration after weight loss.”

Integrative chiropractic role

  • We provide consistent reinforcement through body education—how posture, breath, and movement change the physiology of stress. This improves adherence and reduces fear.

Practical Protocols and Checklists

Hormone care calibration

  • Evaluate symptoms: sleep, mood, bleeding, libido, energy.
  • Labs: estradiol, progesterone, total and free testosterone, SHBG, hematocrit, PSA (males), lipids, and liver enzymes.
  • Imaging for abnormal bleeding: transvaginal ultrasound; biopsy if indicated.
  • Adjust doses conservatively; recheck in 6–8 weeks.

UTI management

  • Culture-directed therapy; avoid treating non-dominant organisms.
  • Support hydration, bladder habits, and pelvic floor function.
  • Recurrent infections: consider urologic evaluation and address glycemic control.

ADHD/anxiety sleep plan

  • Sleep hygiene, circadian anchoring, aerobic activity, and resistance training.
  • Gut support: fiber, polyphenols, fermented foods if tolerated.
  • Behavioral counseling; medication only after foundational changes.

Thyroid monitoring

  • Test based on symptoms; avoid indiscriminate screening without a clinical rationale.
  • Iodine supplementation only when indicated; monitor for hyper- or hypothyroid shifts.

Integrative chiropractic elements

  • Autonomic downregulation: breathing, ribcage mechanics, cervical care.
  • Pelvic balance: sacroiliac alignment, pelvic floor coordination.
  • Rehabilitation: graded strength, mobility routines, gait, and balance work.

Clinical Observations From Practice

From my work at ChiroMed and across collaborative settings, I have repeatedly witnessed:

  • Patients discontinuing high-risk combined oral contraceptives experience increased vigor and reduced fatigue after SHBG levels normalize.
  • Treating structural uterine pathology allows for the resumption of hormone therapy without recurrent bleeding, restoring quality of life.
  • Thoughtful testosterone dosing with emphasis on function, not just numbers, reduces side effects and anxiety.
  • Integrative chiropractic care consistently improves adherence to medical plans by decreasing pain, enhancing sleep, and stabilizing autonomic tone.

Integrative Care Makes the Difference

What ties these threads together is the understanding that the body is an orchestra of signals. Hormones, nerves, muscles, vessels, and organs all participate. By aligning biomechanics and nervous system tone with precise medical interventions, we help the body integrate rather than fight change. The result is care that is safer, more humane, and more effective.

References

Evidence-Based Integrative Hormone Care

Evidence-Based Integrative Hormone Care

Evidence-Based Integrative Hormone Care

Endometrial Health, Thrombosis Safety, Pain, Hair, and Patient-Centered Systems

Abstract

In this educational post, I walk you through how I design and deliver patient-centered, evidence-based care across hormones, endometrial health, thrombosis risk, pain and musculoskeletal function, hair physiology, and practical clinical systems. I explain the physiology behind each decision, why route and dose matter for estrogen, progesterone, and testosterone, how we interpret endometrial thickness and select biopsy methods, and why non-oral estradiol reduces the risk of venous thromboembolism. I share protocols to prevent testosterone-induced erythrocytosis, guide fertility counseling, and manage acne and hair shedding with a stable pharmacokinetic profile. Throughout, I show how integrative chiropractic care strengthens autonomic regulation, venous and lymphatic return, pelvic mechanics, and pain modulation, improving tolerance and outcomes. You will see the latest findings from leading researchers and how I apply them, visit by visit, with systems that keep patients supported and safe.

Introduction: My Integrative Approach to Complex Care

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In daily practice, I manage patients whose needs span endocrinology, gynecology, hematology, cardiometabolic health, neuromuscular pain, and performance. Excellent outcomes rarely depend on a single intervention; they come from a reliable care system: clear intake, structured follow-up, proactive side-effect management, and consistent communication. When we blend modern research methods with hands-on chiropractic-informed strategies and functional medicine principles, patients gain clarity, safety, and momentum.

What follows is the step-by-step journey I use to:

  • Align care with patient priorities through goal-concordant planning.
  • Choose hormone routes and doses that fit physiology and risk.
  • Interpret endometrial health with ultrasound, histology, and modern molecular adjuncts.
  • Reduce thrombosis risk using non-oral estrogen and careful testosterone monitoring.
  • Stabilize pain, sleep, and autonomic balance with integrative chiropractic care.
  • Manage hair health, acne, and metabolic drift with steady-state pharmacokinetics.
  • Build systems—checklists, schedules, micro-interventions—that make care predictable.

Core Patient-Centered Workflow: Systems that Prevent Dropout and Improve Safety

Patients judge success by whether we address their top three priorities. My system ensures those priorities drive decisions and scheduling:

  • Identify and document the patient’s top three goals at the start.
  • Pre-schedule next visits so that at least 90% leave with follow-up in place.
  • Use a structured side-effect checklist to detect issues early.
  • Apply communication scripts and provisional bookings to protect continuity.
  • Set a follow-up cadence: every 4–6 weeks for early stabilization, then extend based on lab and symptom stability.

Why this works: When patients can see the plan—and we guide them through it—adherence rises, and avoidable complications fall. Momentum prevents the stop-start patterns that lead to frustration, missed labs, and poor outcomes. My clinic observations at ChiroMed consistently show that pre-scheduled follow-ups and clear written care plans raise satisfaction and reduce detours (Chiromed.com; Jimenez, LinkedIn).

Integrative Chiropractic Care: The Physiologic Amplifier

Integrative chiropractic is not an add-on; it is a physiological amplifier. Hormones shift sleep, mood, vascular tone, and pain perception. When we optimize neuromuscular balance and autonomic function, patients tolerate medication better and experience smoother relief.

Key pillars and why they matter:

  • Autonomic regulation: Gentle spinal adjustments and soft-tissue work modulate the sympathetic-parasympathetic balance. Improved vagal tone supports sleep, digestion, and inflammatory resolution—critical when initiating progesterone, which exerts GABAergic sedative effects.
  • Pelvic mechanics and circulation: Restoring lumbosacral and pelvic girdle motion improves venous and lymphatic outflow, reducing pelvic congestion, cramping, and pressure that co-occur with abnormal bleeding.
  • Pain modulation: Manual therapy stimulates mechanoreceptors that dampen nociception and hyperalgesia. Fluctuating estrogen and progesterone can alter pain thresholds; chiropractic helps stabilize responses.
  • Exercise prescriptions: Low-impact strength, mobility, and breathing drills improve diaphragmatic tone, sleep quality, and recovery.

Clinical observations from my practice show that combining evidence-based medical therapy with chiropractic-guided plans produces better sleep, fewer pain flares, and a more stable mood (Chiromed.com; Jimenez, LinkedIn). This multimodal synergy creates sustainable improvement.

Progesterone Physiology and Practical Use: Sleep, Mood, and Endometrial Stability

Progesterone is central to managing abnormal uterine bleeding, sleep disturbances, and perimenopausal symptoms. Physiologically, progesterone:

  • Drives endometrial differentiation to the secretory state, countering estrogen’s proliferative effect.
  • Acts via neurosteroid metabolites like allopregnanolone on GABA-A receptors, producing anxiolytic and sedative effects that improve sleep.
  • Modulates inflammatory cytokine signaling, potentially reducing pelvic pain in inflammatory endometrial states.

Clinical indications:

  • Abnormal uterine bleeding when estrogen is relatively unopposed.
  • Sleep support during perimenopause and menopausal transitions.
  • Endometrial protection as part of estrogen therapy.

Formulation and dosing strategy:

  • Oral micronized progesterone (e.g., 200 mg at bedtime): Predictable systemic absorption and helpful somnolence when sleep support is desired. First-pass metabolism varies among patients, and some experience grogginess; we titrate dose and timing to align with goals.
  • Sublingual/buccal troches (e.g., 200 mg): Rapid absorption and reduced first-pass metabolism; less somnolence, preferred when daytime clarity is essential.
  • Quality matters: High-quality compounded formulations minimize excipient variability and allergen exposure (e.g., oil-based excipients), resulting in more consistent bioavailability and fewer erratic symptom cycles.

Why details matter: Align pharmacodynamics with patient goals. If sleepiness is helpful, we leverage it. If daytime function is critical, we shift to non-sedating schedules or formulations. Consistency builds confidence in the dose-response and reduces symptom cycling.

Endometrial Health: Thickness, Imaging, and Biopsy Decisions

The endometrium is highly responsive to hormonal balance. Ultrasound-measured endometrial thickness and tissue patterns guide risk stratification and biopsy decisions:

  • Thickness thresholds: In postmenopausal contexts, a properly timed ≤4 mm thickness often indicates a low immediate risk of endometrial carcinoma, per typical guidelines, when history and symptoms align.
  • Patterns and heterogeneity: Focal masses, polyps, or heterogeneous echotexture raise suspicion for polyps, hyperplasia, or neoplasia.
  • Biopsy selection:
    • Tissue biopsy remains the gold standard for histologic confirmation when imaging or symptoms indicate focal pathology or possible hyperplasia/cancer.
    • Liquid biopsy is an evolving adjunct that detects circulating tumor signals, promising but complementary to tissue histology for endometrial disease.

Clinical reasoning: If ultrasound shows benign features and low thickness while symptoms stabilize, the immediate cancer risk is low for that episode. Persistent or recurrent bleeding demands follow-through, regardless of a single reassuring test. We educate patients that good biopsy results are not the end of monitoring; symptoms still drive surveillance.

Hormone Routes and Thrombosis Safety: What Leading Research Shows

Route choice changes risk. Modern cohort analyses and meta-analytic data consistently demonstrate that oral estrogen induces hepatic synthesis of coagulation proteins, whereas transdermal estradiol bypasses the liver and is associated with neutral venous thromboembolism (VTE) risk in many populations.

What the data show:

  • Oral estrogen upregulates coagulation factors (e.g., factor VII and fibrinogen), thereby increasing VTE risk in some groups.
  • Transdermal estradiol has minimal effects on coagulation markers and is associated with neutral VTE profiles in large observational cohorts (Canonico et al., 2016; Vinogradova et al., 2019).
  • Micronized progesterone appears to have a neutral effect on VTE risk compared with certain synthetic progestins, which can increase risk when combined with oral estrogens (Stute et al., 2016).

Why I prefer non-oral starts:

  • For patients with prior clots, thrombophilias, or perioperative risk, non-oral estradiol protects hepatic coagulation balance.
  • Bedtime micronized progesterone synergizes with sleep architecture via GABAergic pathways.
  • Testosterone is best managed with carefully titrated non-oral options to avoid supraphysiologic peaks that can drive erythrocytosis.

Testosterone, Erythropoiesis, and Hematocrit: Mechanisms and Monitoring

Testosterone stimulates erythropoiesis by increasing erythropoietin (EPO) sensitivity and marrow response. Elevated hematocrit increases blood viscosity, especially above 52–54%, interacting with dehydration, smoking, and sleep apnea to raise risk.

My monitoring plan:

  • Baseline CBC, then at 3 months, 6 months, and every 6–12 months.
  • If hematocrit exceeds thresholds (e.g., 52–54%), lower the dose, extend intervals, evaluate for sleep apnea and hydration status, and consider therapeutic phlebotomy if indicated (Corona et al., 2014; Pastuszak et al., 2015).

Why dose matters: Erythrocytosis is dose-related and reversible. The goal is to maintain energy, libido, and mood benefits while keeping hematocrit within safe limits. We also coordinate with nephrology in CKD contexts to balance anemia management with hemodynamic safety.

Fertility and the Gonadal Axis: Counseling and Alternatives

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, lowering LH/FSH, reducing intratesticular testosterone, and decreasing sperm production. This effect is typically reversible over months after cessation.

Counseling steps:

  • Avoid starting testosterone when planning conception.
  • Consider HCG or SERMs under careful supervision to maintain intratesticular testosterone and support spermatogenesis.
  • Set expectations: recovery of sperm count can take up to 12 months, depending on baseline sperm count and the duration of suppression.

Stable Pharmacokinetics: Why Smooth Curves Beat Spikes

Short-acting hormonal modalities often create spike-and-crash profiles: transient peaks drive acne, irritability, fluid shifts, and receptor sensitization; troughs lead to fatigue and reduced efficacy. Longer-acting or split-dose strategies produce smoother curves with fewer adverse events.

Practical strategies:

  • Use smaller, more frequent injections to reduce peaks and troughs.
  • Prefer steady transdermal systems with consistent absorption.
  • Time labs relative to dosing to capture true troughs and peaks for precise titration (Pilz et al., 2015; Corona et al., 2022).

Clinical observation: Patients report dramatic improvements early after a large injection, then crash by day six. Dividing doses stabilizes energy and reduces acne. My ChiroMed experiences show better adherence and satisfaction when we minimize peaks and synchronize dosing with lifestyle and movement plans (Chiromed.com; Jimenez, LinkedIn).

Hair Physiology, DHT, and Shedding: Understanding the Transition

Hair cycles include anagen (growth) and telogen (shedding). When metabolism reactivates with hormone optimization, shedding can transiently increase as telogen hairs release to make room for new anagen growth. This is a transition, not failure.

Key points:

  • DHT (via 5-alpha-reductase) miniaturizes hair follicles in genetically susceptible individuals; testosterone itself does not directly cause hair loss without conversion to DHT and susceptibility.
  • Assess DHT, thyroid status, ferritin, vitamin D, and family history of androgenetic alopecia.
  • Manage DHT-driven loss with 5-alpha-reductase modulation when indicated, alongside scalp microcirculation support and mitochondrial health.

Supportive measures:

  • Nutritional optimization: protein, iron stores, B vitamins, and vitamin D near personalized targets.
  • Scalp care: minoxidil, gentle topicals for women, light-based therapies for men with sensitive skin.
  • Integrative strategies: diaphragmatic breathing and ribcage mobility to enhance perfusion and nitric oxide bioavailability; consider spermidine to support autophagy and follicle energetics (Holick, 2017; Eisenberg et al., 2019; Lanzillo et al., 2020).

Acne, Aromatization, and Dose Smoothing

Sharp androgen peaks stimulate sebaceous activity and keratinocyte proliferation. Smoother dosing profiles reduce acne. If aromatization spikes estradiol, we adjust testosterone dose before adding aggressive aromatase inhibition to protect bone and lipids. Skin protocols differ by sex and sensitivity:

  • Women: gentle salicylic acid; escalate to retinoids if needed; align with dose smoothing.
  • Men: if salicylic acid irritates, consider intense pulsed light (IPL), and prioritize pharmacokinetic smoothing.

Hypertension and Beta Blockers: Modern First-Line Reasoning

Beta blockers are no longer first-line for uncomplicated hypertension without compelling indications. Contemporary evidence favors thiazides, ACE inhibitors/ARBs, or calcium channel blockers for primary hypertension due to better stroke risk reduction and metabolic profiles (Wiysonge et al., 2017; Messerli et al., 2018).

What I do:

  • Reassess long-standing beta blocker use; confirm indications (post-MI, arrhythmias, heart failure).
  • Transition to guideline-preferred agents when appropriate.
  • Use chiropractic care to improve baroreflex sensitivity, breathing mechanics, and stress modulation; patients often experience more stable blood pressure variability along with movement prescriptions.

Infection Control and Post-Procedure Safety: Culture-Guided Action

Early post-procedure windows (days 7–14) are critical for catching wound complications before abscess formation. I schedule a 7-day in-person check and coach patients to send clear photos of their wounds if changes occur.

Why culture first:

  • Culture-guided therapy allows the use of narrow-spectrum antibiotics tailored to susceptibility, reduces resistance, and prevents symptom chasing.
  • If an abscess is present, perform incision and drainage; antibiotics alone cannot treat closed purulent collections (Stevens et al., 2014).
  • Build pre-op checklists (e.g., MSSA/MRSA screening and decolonization) and audit workflow compliance.

Chiropractic role:

  • Gentle autonomic regulation via breathing training and low-load mobility supports microcirculation and healing.
  • Regional joint mobilization (when cleared) assists lymphatic and venous return, reducing edema and discomfort.

Practical Medication Transitions: Sertraline and Tricyclics

Beyond hormones, careful pharmacology matters:

  • Sertraline titration should be gradual to avoid activation (anxiety, insomnia). Split dosing can moderate peak plasma concentrations.
  • Tricyclics require attention to CYP450 interactions and QT risk; space timing to avoid peak overlap and monitor EKG when indicated.
  • Reinforce sleep hygiene; poor sleep magnifies activation side effects and destabilizes autonomic tone.

Micro-Interventions and Clinical Checklists: Making Care Stick

High-performing clinics rely on checklists and short, repeatable micro-interventions:

  • Pre-procedure: screening for MSSA/MRSA, consent, wound care education, and scheduling the 7-day check.
  • Post-procedure: early re-check, cultures if draining, photo documentation, pain/function scoring.
  • Hormone transitions: lab scheduling, side-effect diaries, sleep-hygiene reinforcement, communication templates for primary care.

Five-minute interventions—breathing drills, posture resets, movement reminders—stacked across the week build habits, reduce pain, and support adherence without derailing clinic flow.

Putting It Together: A Patient Journey Example

I saw a patient for a scheduled 7-day post-procedure check. They reported mild redness and warmth:

  • We compared local temperature and tenderness to adjacent tissue, noted light serous drainage, and obtained a wound culture before antibiotics.
  • We set a 48–72 hour follow-up aligned to culture processing and documented their top priorities (pain reduction, return to work, and cosmetic healing).
  • Simultaneously, we planned a low-dose bridging approach for their transition from testosterone injections to a steadier regimen and aligned sleep and movement protocols (calf-pump activity and diaphragmatic breathing).
  • Result: targeted antibiotics matched the culture, swelling resolved, and the hormone transition proceeded with minimal side effects. Within four weeks, they met their top priorities and returned to training with improved energy and mood.

Why Integrative Chiropractic Belongs in This Care

The pelvis and spine are not isolated constructs; they interact with hormonal states, autonomic tone, and pain sensitivity. By improving joint mechanics, reducing muscle guarding, and supporting a parasympathetic shift, integrative chiropractic enhances the body’s ability to accommodate medication effects and heal.

Patients commonly report:

  • Better sleep onset and maintenance.
  • Reduced pelvic pressure and cramping.
  • Fewer anxiety flares during dose changes.
  • Enhanced energy and recovery.

My clinical observations reflect that this multimodal approach is both scientifically sensible and practically effective (Chiromed.com; Jimenez, LinkedIn).

Key Takeaways You Can Use Today

  • Prefer non-oral estradiol to minimize the impact on coagulation and VTE risk.
  • Use micronized progesterone at bedtime for endometrial protection and GABAergic sleep support.
  • Monitor hematocrit diligently with testosterone; adjust dose and intervals, assess OSA, hydration, and consider therapeutic phlebotomy when needed.
  • Stabilize pharmacokinetics: avoid short-acting spikes; divide doses for smoother curves.
  • Manage DHT thoughtfully; check thyroid and ferritin for hair health.
  • Employ culture-guided infection management; schedule a 7-day post-procedure check.
  • Build systems: checklists, side-effect diaries, pre-scheduled follow-ups, and micro-interventions.
  • Integrate chiropractic care to optimize autonomic regulation, venous return, pelvic mechanics, and pain modulation.

References

DHEA: Enhancing Your Well-Being With Hormonal Health

Unlock your potential with insights on hormonal health and DHEA as well as its impact on your body’s functions.

Abstract

As a clinician in integrative musculoskeletal and metabolic health, I have spent decades helping patients navigate hormone optimization, metabolic dysfunction, and chronic symptoms that defy quick fixes. In this educational post, I share an evidence-based, first-person roadmap that blends functional endocrinology, integrative chiropractic care, and primary care protocols. I cover how and why sex hormone binding globulin (SHBG) modifies testosterone bioavailability, why we generally avoid suppressing SHBG, and how to navigate SHBG-driven symptoms clinically. I explain polycystic ovary syndrome (PCOS) through a gut–metabolic–endocrine lens, including practical treatment sequencing with GLP-1s, metformin, spironolactone, thyroid hormone, and progesterone optimization, along with nutrition, probiotics, and careful testosterone dosing where appropriate. For men considering testosterone therapy, I outline modern prostate-specific antigen (PSA) strategies that reduce unnecessary biopsies, emphasizing percent-free PSA, PSA velocity, and prostate MRI. Finally, I detail the central nervous system and immunometabolic roles of DHEA, how to test and dose it, and how to integrate it safely into comprehensive hormone care. Throughout, I share clinical observations from my practice and colleagues, focusing on how integrative chiropractic care supports these protocols through autonomic regulation, movement prescription, and anti-inflammatory strategies.

Introduction: Building A Foundation For Smarter Hormone Care

I learned early in my career that “just dosing the pellet” or “just raising the lab number” isn’t enough. My real training came while managing patients over months and years—especially those with “great labs” but persistent fatigue, brain fog, low libido, acne, hirsutism, or sleep disruption. When a patient’s serum looks ideal, yet they still do not feel well, physiology is telling us to widen the lens.
Core lesson from experience:
Hormone signaling depends on more than the hormone molecule. It depends on receptor expression and sensitivity, membrane and nuclear co-activators, nutrient status, thyroid conversion, inflammatory tone, insulin, and the microbiome.
Patients with optimal total testosterone can feel poorly if free fractions are low, androgen receptors are dysregulated by inflammation, or if thyroid and vitamin D are suboptimal.
A vivid case taught me the leverage of micronutrients. Years ago, a long-time patient told me her hormone therapy “just wasn’t working.” Her labs were good; her symptoms were not. We discovered she had stopped taking her vitamin D. I asked her to restart it daily, and if she felt no improvement within three to four months, I promised a refund. She returned about three and a half months later, noticeably improved. “I will never stop vitamin D again.” That experience mirrors the literature showing that vitamin D is a co-regulator of hormone receptor activity and immune tone, impacting how hormones “land” at the tissue level.
In this guide, I’ll walk you through the why beneath the what, so each clinical step is anchored to physiology and research. I’ll also show how integrative chiropractic care fits: regulating autonomic balance, improving movement and sleep, reducing nociceptive input, and lowering systemic inflammation—all of which support endocrine therapies.

Understanding Sex Hormone Binding Globulin SHBG) and Testosterone Bioavailability


Why SHBG Matters


SHBG binds circulating androgens and estrogens—particularly testosterone—governing how much hormone is free and bioactive.
High SHBG can trap testosterone, lowering free testosterone and causing symptoms despite normal or high total testosterone.
Low SHBG often signals metabolic dysfunction. It correlates with insulin resistance, risk of fatty liver, and cardiometabolic disease.

Key Physiology


SHBG is produced in the liver. It is upregulated by estrogens, hyperthyroidism, low insulin, alcohol intake, and lower body mass; downregulated by androgens, insulin, obesity, and hepatic steatosis.
SHBG acts as more than a passive binding protein. Several studies have associated low SHBG with increased risk of type 2 diabetes and all-cause mortality, suggesting it serves as a biomarker of metabolic risk and possibly as a modulator of steroid signaling in hepatocytes and peripheral tissues (Ding et al., 2009; Laaksonen et al., 2004).

Clinical Reasoning: Do Not Reflexively Lower SHBG


Because low SHBG is linked to metabolic syndrome and increased cardiometabolic risk, attempting to suppress SHBG to “raise free T” can be counterproductive.
Instead, we:
Optimize total testosterone within evidence-based ranges to “outcompete” high SHBG.
Address contributors to high SHBG (excess estradiol, alcohol, low protein intake, hyperthyroid states, certain medications) when appropriate.
Improve receptor sensitivity and steroid signaling (thyroid, vitamin D, inflammation, insulin sensitivity).
In selected cases, use targeted nutraceuticals that support androgen economy and estrogen metabolism.

Practical Strategies to Overcome High SHBG


Raise testosterone dose carefully and symptom-guided while monitoring free T and estradiol.
Support hepatic estrogen metabolism and androgen bioavailability:
Nutrients such as diindolylmethane DIM and shilajit may assist estrogen metabolism and mitochondrial function. In my own n-of-1 testing with a compound containing shilajit and DIM, I observed improved free testosterone near the trough period. While anecdotal, this aligns with data indicating that DIM supports phase I estrogen metabolism and that shilajit may influence mitochondrial dynamics and steroidogenesis (Zhu et al., 2020; Pacchetti et al., 2021).
Address lifestyle levers:
Moderate alcohol, ensure adequate dietary protein, optimize thyroid status, and maintain resistance training to enhance androgen receptor density and insulin sensitivity.

Why Integrative Chiropractic Care Helps Here


By reducing musculoskeletal pain and improving movement patterns, we lower sympathetic overdrive. Chronic sympathetic dominance elevates cortisol levels and impairs signaling along the gonadal axis.
Manual therapies, nerve glides, and graded exercise can improve sleep quality and inflammatory tone, enhancing hormone receptor sensitivity over time. In practice, we see better outcomes when patients combine hormonal optimization with structured movement, fascial care, and recovery protocols.

SHBG As A Metabolic Biomarker


Low SHBG often precedes elevations in A1c and fasting glucose, flagging early insulin resistance (Perry et al., 2010).
In women, higher SHBG is associated with lower insulin resistance risk; the opposite trend is observed with low SHBG and high BMI (Ding et al., 2009).

Takeaway


Use SHBG diagnostically, not just therapeutically. Let it inform your metabolic plan. Avoid “chasing free T” by artificially suppressing SHBG; treat the person, not just the lab.

PCOS Root-Cause Thinking: Gut Dysbiosis, Insulin Resistance, Androgen Excess

The Modern PCOS Lens

PCOS is the most common endocrine disorder in women and is frequently misdiagnosed. Not all patients present with the classic triad of obesity, hirsutism, and oligomenorrhea. About half are not overweight.
Many women display a PCOS-like phenotype without ovarian cysts: hyperandrogenic symptoms, acne, irregular cycles, infertility, and insulin resistance.
The Rotterdam criteria: diagnosis requires two of three:
Oligo/anovulation
Clinical or biochemical hyperandrogenism
Polycystic ovarian morphology

Physiology: Gut–Immune–Endocrine Crosstalk


Emerging evidence implicates gut dysbiosis, increased intestinal permeability, and metabolic inflammation as upstream drivers that worsen insulin resistance, elevate LH relative to FSH, and promote ovarian androgen excess (Qi et al., 2019; Lindheim et al., 2017).
Hyperinsulinemia lowers SHBG and directly stimulates ovarian theca cells to produce androgens, increasing free testosterone despite “normal” total testosterone.
Vitamin D, thyroid function, and micronutrients influence androgen receptor function and ovarian steroidogenesis.


Clinical Picture I See Often


Baseline total testosterone is low-to-normal, but free testosterone is disproportionately high because SHBG is suppressed by insulin.
LH: FSH ratio may be >2:1 in some patients. Although the literature debates its reliability, it can be supportive when considered alongside other features.
Symptoms: acne, hirsutism, hair shedding, irregular cycles, subfertility, mood changes, and abdominal weight gain.

An Integrative Treatment Plan That Works


Fix the gut basics first.
Ensure regular bowel movements, basic elimination diet counseling, and introduce a quality probiotic.
While patients vary in readiness for diet change, I begin with a high-quality, multi-strain probiotic and foundational nutrition coaching. Our team has observed favorable outcomes with formulas enriched for Lactobacillus and Bifidobacterium species that support barrier integrity and short-chain fatty acid production. As noted in our nutrition education resources, formulations designed to support the GI barrier and immune crosstalk can accelerate symptom relief.
Why this works
Reducing dysbiosis and LPS translocation lowers systemic inflammation and insulin resistance, thereby reducing ovarian androgen output and raising SHBG, which decreases free androgen excess.
Improved gut function enhances the absorption of micronutrients (iodine, selenium, zinc, magnesium) necessary for thyroid hormone conversion and steroidogenesis.
Target insulin resistance
Metformin: titrate slowly to 2,000 mg/day as tolerated. Start at 500 mg with the evening meal, then stepwise add 500 mg every 1–2 weeks to minimize GI upset. The goal is 1,000 mg twice daily, extended-release when possible.
GLP-1/GIP receptor agonists: semaglutide, tirzepatide, or class peers, if accessible and clinically appropriate. These agents reduce appetite, weight, and inflammation, and improve insulin sensitivity, thereby raising SHBG and lowering free testosterone.
Why this works
Lower insulin levels reduce theca cell androgen production, increase SHBG synthesis in the liver, and restore ovulatory signaling. Over time, menses regularity and ovulatory function return. In my practice, I have seen cycle normalization and improved fertility after 12–36 months of diligent metabolic and hormonal care.
Manage androgenic symptoms while root causes are addressed
Spironolactone for hirsutism and acne in PCOS:
Typical PCOS dose: 100 mg/day. This is one of the few contexts where I use 100 mg in women because androgen excess is both a symptom generator and a psychosocial burden.
For non-PCOS androgenic symptoms, I generally avoid >50 mg/day to prevent excessive androgen blockade and sexual side effects.
Topical options can support acne management.
Expect 6–12 months before a significant improvement in hirsutism due to hair cycle biology.
Protect pregnancy and fertility.
Progesterone support is critical. PCOS patients are frequently progesterone-deficient during early gestation.
I often target at least 200 mg nightly micronized progesterone; in some cases, an additional 100 mg during the day is required.
I aim for luteal progesterone levels above 20 ng/mL, with 24 ng/mL often providing greater clinical reassurance when measured appropriately during the cycle.
Thyroid optimization matters. Subclinical hypothyroidism can disrupt ovulation and increase miscarriage risk. Target symptom-guided euthyroidism with appropriate T4/T3 conversion support, ferritin >50–70 ng/mL, selenium 100–200 mcg/day, and vitamin D optimization.
Testosterone therapy in women with possible PCOS phenotype
If testosterone is indicated for symptomatic women who “look like PCOS” or have insulin resistance, start low and go slow.
In my practice, I avoid starting doses above approximately 75–87.5 mg when using implants in such patients and titrate carefully. These women are more sensitive to free T spikes due to low SHBG and hair follicle sensitivity. Overshooting increases acne and hirsutism.
Lifestyle and integrative chiropractic care
Sleep: normalize circadian rhythm to lower cortisol and improve insulin sensitivity.
Movement: emphasize resistance training and low-impact aerobic conditioning to increase GLUT4 signaling and androgen receptor density in skeletal muscle.
Chiropractic integration: manual therapy and corrective exercise downregulate pain signaling and sympathetic tone, improving adherence to activity and nutrition. At our clinic, blending spinal and regional biomechanics with metabolic counseling improves durability of outcomes and patient engagement (Clinical observations: https://chiromed.com/; https://www.linkedin.com/in/dralexjimenez/).


PCOS Outcomes


With sustained care for the gut, metabolism, and hormones, many women regain regular cycles and ovulation over 12–36 months. I have followed patients who conceived naturally after years of infertility once insulin and inflammation were reduced, thyroid and progesterone were optimized, and lifestyle became sustainable.

PSA, Percent-Free PSA, PSA Velocity, And Prostate MRI In Men On Or Considering Testosterone


What Changed in the Last Decade


PSA alone is an imperfect cancer biomarker: specific but not sensitive. Many nonmalignant factors raise PSA: prostate massage, ejaculation, cycling, prostatitis, and benign prostatic hyperplasia BPH.
Percent-free PSA improves sensitivity. A lower percent-free PSA indicates a higher likelihood of prostate cancer.
PSA velocity matters. A rapid rise from baseline is more concerning than an isolated value.


How I Screen and Refer


Baseline PSA before initiating testosterone therapy in men, with shared decision-making consistent with American Urological Association guidance (AUA, 2023).
If PSA is elevated or rises rapidly, automatically reflex to percent-free PSA when the lab allows. Many laboratories can set an auto-reflex rule when PSA exceeds 4.0 ng/mL; you can request this configuration.

Interpreting Percent-Free PSA


Percent-free PSA <10%: higher likelihood of malignancy; urology referral and/or prostate MRI is strongly considered.
Percent-free PSA 10–25%: intermediate zone; evaluate for prostatitis symptoms, consider empiric management and repeat testing, and consider MRI based on shared decision-making.
Percent-free PSA >25%: lower likelihood; monitor and reassess.

Remember Finasteride

5-alpha-reductase inhibitors (finasteride/dutasteride) reduce PSA by ~50%. Double the measured PSA to estimate the “true” value for risk assessment.

PSA Velocity Example

A jump from 0.9 to 2.9 ng/mL over a year represents a significant increase associated with a higher risk. Some urology practices may not act on a “low” absolute PSA, but the velocity and low percent-free PSA can justify expedited evaluation.

Multi-parametric has become the preferred next step

Multi-parametric prostate MRI is now a gold-standard triage tool. It detects clinically significant lesions, grades risk with PI-RADS, and can identify prostatitis or prominent BPH.
MRI can reduce unnecessary biopsies and better target biopsies when indicated (Ahmed et al., 2017; Kasivisvanathan et al., 2018).
MRI is not confounded by recent ejaculation or prostate manipulation in the way total PSA can be. Percent-free PSA also remains stable relative to such perturbations.

Clinical Pathway I Use


Baseline PSA and DRE as indicated.
If PSA is above the threshold or velocity is high:
Order percent-free PSA.
If percent-free PSA <10% or MRI PI-RADS suggests a clinically significant lesion: refer to urology for targeted biopsy.
If MRI shows prostatitis/BPH without suspicious lesions, treat and monitor; repeat PSA/percent-free PSA after an appropriate interval.
Testosterone therapy after prostate cancer workup
Current guidance allows resumption or initiation of testosterone therapy in select men with a normalizing PSA and no active disease, via shared decision-making with urology (AUA, 2018 update; Pastuszak & Khera, 2015). The dogma of indefinite deferral has softened with better risk stratification.

DHEA: Beyond A Precursor—Neurosteroid, Immunomodulator, And Metabolic Ally


What We Now Know


Dehydroepiandrosterone DHEA and its sulfated form DHEA-S are not merely precursors. DHEA acts as a neurosteroid with receptors and modulatory effects in the central nervous system and immune system (Maninger et al., 2009; Labrie et al., 2005).
DHEA declines steeply with age—more sharply than testosterone—and this decline correlates with changes in mood, immune robustness, bone turnover, and cardiometabolic health.

Physiology Highlights

Source: adrenal zona reticularis and, to a lesser degree, CNS synthesis.
Conversion: DHEA interconverts with androstenedione and downstream sex steroids; however, DHEA exerts independent effects on GABAergic, glutamatergic, and sigma-1 receptors, and modulates neuroinflammation.
Immune: DHEA enhances natural killer cell activity and can counter-regulate cortisol’s catabolic and immunosuppressive effects (Kharigaokar et al., 2022).
Vascular: associations with endothelial function and modulation of atherosclerosis risk have been reported, especially in women (Shufelt et al., 2010).

Clinical Uses I Have Found Most Impactful


Residual low energy, blunted libido, and low resilience despite optimized thyroid and sex steroids—especially in women—often reflect low DHEA-S.
Chronic stress phenotype with central adiposity, sleep disruption, and anxiety may show high cortisol/low DHEA-S. Repleting DHEA-S can rebalance the cortisol–DHEA axis and improve stress tolerance.

Testing and Target Ranges


Test DHEA-S, not just DHEA. DHEA-S is more stable and better reflects adrenal throughput.
Laboratory “normal” ranges are wide and population-based. I individualize within the upper-normal tertile for symptom relief while monitoring for androgenic side effects.
Women: I often aim for mid-to-upper range appropriate for age, not exceeding the lab’s upper limit without a clear rationale.
Men: similar philosophy—optimize within age-adjusted upper-normal if symptomatic and low at baseline.

Dosing Strategy

Start low, reassess, titrate slowly. For compounded prescription-grade DHEA, I prefer quality-controlled products to ensure accurate dosing.
Women: 5–25 mg/day, commonly 10–20 mg/day. Start at the lower end in younger women or those prone to acne/hair shedding.
Men: 25–50 mg/day, commonly 25–40 mg/day.
Recheck DHEA-S in 6–8 weeks and monitor lipids, liver enzymes, and androgenic symptoms.
Limitations:
In PCOS, DHEA-S may already be elevated; avoid adding DHEA without a documented deficiency.
Watch for acne, oily skin, or hair changes; these suggest excess conversion to DHT.

Why It Works

DHEA’s neurosteroid effects can improve motivation and sexuality beyond what testosterone alone provides. DHEA also contributes to local intracrine androgen/estrogen balance in tissues, including the brain, bone, and vaginal mucosa (Labrie et al., 2017).
In my practice, layering DHEA into a well-structured program has repeatedly improved libido and mood in patients (especially women) who were otherwise optimized on thyroid and sex steroids.

Integrative Chiropractic Care: The Missing Link In Hormone Outcomes

The Autonomic–Endocrine Connection

Pain, poor sleep, and immobility drive sympathetic dominance and HPA axis activation. Elevated cortisol impairs gonadal function, thyroid conversion, and insulin sensitivity.
By restoring joint mechanics, reducing nociceptive signaling, and promoting diaphragmatic breathing and parasympathetic tone, integrative chiropractic care improves the neuroendocrine environment in which hormone therapies can work.


How We Implement It

Manual therapy to reduce segmental dysfunction and myofascial tension.
Individualized corrective exercise to build strength and insulin sensitivity, particularly gluteal and posterior-chain dominance for metabolic health.
Recovery protocols: sleep hygiene, vagal stimulation through paced breathing, and light exposure strategies.
Nutrition and supplementation guidance: vitamin D sufficiency, omega-3 intake, magnesium repletion, and protein adequacy—all essential for hormone receptor function and musculoskeletal repair.
Observed benefits in the clinic
Patients marrying hormone therapy with structured musculoskeletal care report more stable energy, better sleep, superior adherence to resistance training, and more durable symptom control. In our practice, this integrated plan consistently outperforms hormone-only or exercise-only approaches (Clinical observations: https://chiromed.com/; https://www.linkedin.com/in/dralexjimenez/).

Putting It All Together: A Stepwise Protocol


Assessment
History and goals; menstrual and fertility history; sexual function; sleep, pain, stress.
Labs:
CBC, CMP, fasting insulin, fasting glucose, A1c, lipid panel, and hs-CRP.
Thyroid panel with TSH, free T4, free T3, thyroid antibodies as indicated.
25-hydroxyvitamin D.
Total testosterone, free testosterone, estradiol, SHBG.
DHEA-S.
In men: PSA with reflex percent-free PSA if available; note finasteride.
Body composition and blood pressure; consider continuous glucose monitoring for insulin resistance phenotypes.
Interventions
Gut and lifestyle:
Regular bowel movements, probiotic initiation, fiber 25–35 g/day, protein 1.2–1.6 g/kg/day, omega-3 repletion, and vitamin D to 40–60 ng/mL.
Resistance training 2–4x/week; low-impact cardio; sleep 7.5–8.5 hours; alcohol moderation.
Integrative chiropractic care to decrease pain, normalize movement, and support autonomic balance.
Insulin resistance:
Metformin was titrated to 2,000 mg/day as tolerated.
GLP-1 or GLP-1/GIP agonists where appropriate and accessible.
Androgen management:
For PCOS: spironolactone 100 mg/day for hirsutism/acne; expect 6–12 months for maximal hair effects.
Testosterone in women with PCOS phenotype: start low-dose and titrate cautiously; monitor free T and symptoms.
Thyroid and progesterone:
Optimize thyroid status; address ferritin, selenium, and zinc.
Progesterone support in PCOS, especially if pregnancy is a goal; aim for luteal adequacy.
DHEA:
Add if DHEA-S is low and symptoms persist; start low and titrate based on lab and symptom feedback.
Monitoring
Reassess labs at 8–12 weeks for medication changes; 3–6 months for broader interventions.
In men on testosterone: PSA and percent-free PSA per guideline intervals; consider MRI if risk signals appear.
Track patient-reported outcomes: energy, libido, sleep, menses regularity, skin/hair changes, and training capacity.
Why This Works: The Physiology In One View
Lower insulin raises SHBG and dampens ovarian and adrenal androgen excess.
Vitamin D and thyroid hormones optimize receptor transcription and mitochondrial function, amplifying the hormonal signal.
DHEA restores neurosteroid tone and immune balance, reducing the “stress drag” on the HPG axis.
Movement and manual care improve insulin sensitivity and vagal tone, lowering cortisol and improving receptor responsiveness.
PSA strategies that include percent-free PSA and MRI provide safer testosterone care for men by reducing false positives and unnecessary biopsies.

Closing Thoughts

I began this work focused on “getting the number right.” Over the years, I learned that the patient gets better when we get the physiology right. That means connecting the gut and liver to hormones, sleep to insulin, vitamin D to receptors, pain to cortisol, and movement to mitochondrial health. When you put these pieces together—root-cause metabolic care, precise hormone management, DHEA where it belongs, modern PSA strategy, and integrative chiropractic support—the results compound.

Citations

  • Ahmed, H. U., El-Shater Bosaily, A., Brown, L. C., Gabe, R., Kaplan, R., Parmar, M.K., multi-parametric M. (2017). Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer PROMIS: a paired validating confirmatory study. The Lancet. https://doi.org/10.1016/S0140-6736(16)32401-1
  • American Urological Association. (2018, updated 2023). Early Detection of Prostate Cancer: AUA Guideline. https://www.auanet.org/guidelines/early-detection-of-prostate-cancer
  • Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2009). Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. https://doi.org/10.1001/jama.2009.130
  • Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., … & PRECISION Study Group. (2018). MRI-targeted or standard biopsy for prostate cancer diagnosis. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa1801993
  • Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2005). DHEA and intracrinology. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2005.08.002
  • Labrie, F., Archer, D. F., Koltun, W., Vachon, A., Young, D., Frenette, L., … & Plante, M. (2017). Efficacy of intravaginal DHEA on moderate to severe dyspareunia. Menopause. https://doi.org/10.1097/GME.0000000000000801
  • Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T. P., Valkonen, V. P., … & Salonen, J. T. (2004). Sex hormones, SHBG, and metabolic syndrome in middle-aged men. Diabetes Care. https://doi.org/10.2337/diacare.27.5.1036
  • Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone DHEA and DHEA-sulfate DHEAS. CNS Drugs. https://doi.org/10.2165/00023210-200923070-00004
  • Pastuszak, A. W., & Khera, M. (2015). Testosterone therapy after prostate cancer. The Journal of Urology. https://doi.org/10.1016/j.juro.2014.09.110
  • Perry, J. R., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., … & Frayling, T. M. (2010). Genetic evidence that raised sex hormone binding globulin SHBG) Levels reduce the risk of type 2 diabetes. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq316
  • Qi, X., Yun, C., Pang, Y., & Qiao, J. (2019). The impact of the gut microbiota on the reproductive system. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaz013
  • Shufelt, C., Bretsky, P., Almeida, C. M., Johnson, B. D., Shaw, L. J., Azziz, R., & Bairey Merz, C. N. (2010). DHEA-S levels and cardiovascular disease mortality in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-0302
  • Zhu, B. T., Lee, A. J., & Conney, A. H. (2020). Effects of indole-3-carbinol and its dimer diindolylmethane on estrogen metabolism. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.29488
  • Pacchetti, B., Ghezzi, L., & Galimberti, D. (2021). Shilajit: a herbo-mineral exudate for mitochondrial health. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.656924

Refermulti-parametric


SEO tags: SHBG, free testosterone, testosterone therapy, PCOS, insulin resistance, GLP-1, metformin, spironolactone, progesterone, thyroid optimization, DHEA, DHEA-S, neurosteroid, PSA, percent-free PSA, PSA velocity, prostate MRI, integrative chiropractic, functional endocrinology, vitamin D, women’s health, men’s health, fertility, hirsutism, acne, Rotterdam criteria, metabolic syndrome, gut dysbiosis, microbiome, autonomic regulation, clinical protocol